John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 165,084 shares at $37.14 ($6.1M) on 2025-10-31, disclosed to the SEC on 2025-11-04.
Scheduled sale ($6.1M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.14 | 82,542 | $3.1M | 50.0% |
| 2 | $37.14 | 82,542 | $3.1M | 50.0% |
| Total | $37.14 avg | 165,084 | $6.1M | 100% |
| Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |
| KNSA | SELL | 2024-09-04 | $3.1M | — | Filing → |